FDA partly to blame in EpiPen price debacle

Published



The anger over EpiPen’s 400 percent price spike may be giving some people deja vu.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.